Reig Jofre in brief

Founded in 1929, Reig Jofre is a Spanish pharmaceutical company whose business is divided into two major areas: one main for the marketing and manufacture of own developments (RJF Pharma, 80% of total sales) and one of specialized contract development and manufacturing (RJF CDMO, 20% of total sales). At its core activity, the company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynaecology and respiratory; and consumer healthcare products. The company directs its R&D to develop new indications and/or dosage forms of already-known active ingredients, generic medicines with a special focus on the development of beta-lactam antibiotics and injectable, topical dermatological products, OTCs and food supplements as well as the development of new innovative molecules in partnership with start-ups and biotech research centres.

Reig Jofre has 900 employees, 4 development centers and 3 manufacturing sites in Europe, direct sales in 6 countries in Europe and over 130 commercial partners in 58 countries worldwide.

The company trades on the Spanish stock exchange under the ticker RJF, and is #5 Spanish pharmaceutical company by turnover in Spain.

Member of:


This site uses only technical third party cookies to provide better service, when browsing this website you agree to its use. See ourlegal advice. Agree

DMC Firewall is developed by Dean Marshall Consultancy Ltd